IRF1 and head and neck squamous cell carcinoma: Recent studies have indicated that in head and neck squamous cell carcinoma (HNSCC) cells, the knockdown of IRF1 can reduce the expression levels of IFI44L and suppress cell proliferation and invasiveness.